Adia Nutrition, Inc.
Adia Nutrition, Inc. (OTC: ADIA) is a $10M shell companies company trading at $0.15 (−3.2% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:28 UTC.
Adia Nutrition, Inc. (OTC: ADIA) is a $10M shell companies company trading at $0.15 (−3.2% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:28 UTC.
ADIA Nutrition, Inc., incorporated in Nevada in 1975 under different names, was revived from shell status in 2022 after years of inactivity and charter revocation. The company changed control in January 2024 and transitioned to operating business by acquiring Biolete LLC in June 2024, ceasing shell company status. ADIA now operates medical clinics and laboratories focused on stem cell therapies, including Umbilical Cord Stem Cell treatments and Autologous Hematopoietic Stem Cell Transplantation, along with supplement products registered with the FDA.
Summarized from Adia Nutrition, Inc.’s SEC filings · Read the filing ↗
| Quote | |
| Price | $0.15 |
| Change (1D) | -0.01 (-3.25%) |
| Market cap | $10M |
| Volume | 32.5K shares |
| 52-week range | $0.02 – $0.28 |
| Valuation | |
| EPS (TTM) | $0.00 |
| Return on equity | 153.47% |
| Returns | |
| 52-week return | +581.9% |
ADIA Nutrition, Inc., incorporated in Nevada in 1975 under different names, was revived from shell status in 2022 after years of inactivity and charter revocation.
ADIA trades at $0.15, as of 2026-07-15.
Adia Nutrition, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-05-15. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:28 UTC. This page is also available as JSON at /api/data?ticker=ADIA and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ADIA and 3,500+ tickers.
Create a free account — keep ADIAGET /api/data?ticker=ADIA
This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt